Product Information

SANDOSTATIN LAR DEPOT 20 MG KT is a brand product labeled by Novartis Pharmaceuticals Corporation, priced at $4412.0643 per EA under NDC 00078081881. Its NADAC has been published 71 times since Feb 19, 2025.

The High Outlier badge above means this manufacturer's average price in the octreotide acetate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

SANDOSTATIN LAR DEPOT 20 MG KT

octreotide acetate
$4412.0643per EA
High Outlier

NDC

00078081881

Classification

Brand

Dosage Form

KIT

Last Updated

6/17/2026

Approval Type

New Drug (NDA)

FDA Application

NDA021008

On Market Since

7/22/2016

Price Statistics

The NADAC for SANDOSTATIN LAR DEPOT 20 MG KT has been published 71 times since Feb 19, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$4412.0643 per EA
All-time high$4468.6220 (Apr 16, 2025)
All-time low$4408.5529 (Dec 17, 2025)
52-week high$4456.9783
52-week low$4408.5529
Median price$4443.4671
Average price$4436.0123
Largest weekly change-0.6% (Dec 17, 2025)
Weeks tracked71
Tracking sinceFeb 19, 2025

Price History

1W

0.0%

1M

0.0%

3M

+0.1%

6M

+0.1%

1Y

-1.0%

3Y

N/A

5Y

N/A

All

-1.3%

Generic Alternatives

The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 23% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of SANDOSTATIN LAR DEPOT 20 MG KT?

The current National Average Drug Acquisition Cost (NADAC) for SANDOSTATIN LAR DEPOT 20 MG KT, manufactured by Novartis Pharmaceuticals Corporation, is $4412.0643 per EA (NDC 00078081881), effective Jun 24, 2026.

How has the price of SANDOSTATIN LAR DEPOT 20 MG KT changed over time?

Over the history we have for it, the NADAC for SANDOSTATIN LAR DEPOT 20 MG KT has held within roughly two percent of its current level. It has been tracked across 71 weekly CMS publications since Feb 19, 2025.

What are the highest and lowest recorded NADAC prices for SANDOSTATIN LAR DEPOT 20 MG KT?

Since Feb 19, 2025, the NADAC for SANDOSTATIN LAR DEPOT 20 MG KT has ranged from a low of $4408.5529 (Dec 17, 2025) to a high of $4468.6220 (Apr 16, 2025), with a median of $4443.4671 per EA.

Are there cheaper alternatives to SANDOSTATIN LAR DEPOT 20 MG KT?

Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, SANDOSTATIN LAR DEPOT 10 MG KT, is $3387.5280 per EA — about 23% below SANDOSTATIN LAR DEPOT 20 MG KT.

Who manufactures SANDOSTATIN LAR DEPOT 20 MG KT?

SANDOSTATIN LAR DEPOT 20 MG KT (NDC 00078081881) is labeled by Novartis Pharmaceuticals Corporation, and CMS classifies it as a brand product.

Related Drugs

Same classification

No related drugs found.